Headlands Technologies’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Headlands Technologies’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,182	Closed	-$374K	–	1607
2023 Q4	$374K	Buy	+1,182	New	+$230K	0.11%	173
2023 Q3	–	Sell	-1,610	Closed	-$349K	–	1271
2023 Q2	$349K	Buy	1,610 +1,527	+1,840%	+$327K	0.11%	205
2023 Q1	$15.1K	Buy	+83	New	+$15.9K	0.01%	310

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Headlands Technologies's KRTX Position: Q1 2024 in Review

Headlands Technologies sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1,182 shares — an estimated $374K sold.

Headlands Technologies first reported a position in KRTX in Q1 2023 and held it in 3 quarters. The position peaked at $374K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Headlands Technologies reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Headlands Technologies sold 1,182 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $374K.
Headlands Technologies first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
Headlands Technologies's Karuna Therapeutics, Inc. Common Stock position peaked at $374K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Headlands Technologies's 13F filing for Q1 2024, filed 7 May 2024.